GLP-1 receptor agonists are not exclusively prescribed for weight loss
The study suggests that GLP-1s "have a key role in kidney-protective and heart-protective treatment for patients with common medical conditions like Type 2 diabetes, overweight or obesity with cardiovascular disease, or chronic kidney disease," he said in a news release
The SURMOUNT trials showed tirzepatide produced slightly higher weight loss (15-21%) compared to semaglutide (15-17%) in head-to-head comparisons
How often will I need to visit LCMC Health Urgent Care in-person? After your initial consultation which includes an evaluation, vitals, lab testing, a review of your diet and exercise routine, and goal setting youll return once a month for follow-up evaluations
Because they work by augmenting lacking nutrients in the body, they help increase energy levels, improve brain functions, and reduce weight